Damora Therapeutics (DMRA) Operating Leases (2019 - 2025)
Damora Therapeutics (DMRA) reported Operating Leases of $53000.0 for Q4 2025, down 13.11% on a YoY basis from $61000.0 in Q4 2024, and down 7.02% quarter-over-quarter from $57000.0 in Q3 2025.
Damora Therapeutics (DMRA) Operating Leases (2019 - 2025) Analysis & Trends
Damora Therapeutics has reported Operating Leases for 7 years, with the latest figure at $53000.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases fell 13.11% year-over-year to $53000.0; the trailing twelve-month figure through Dec 2025 stood at $53000.0 (down 13.11% YoY), and the FY2025 full-year result was $53000.0, down 13.11% from the prior year.
- Operating Leases for Q4 2025 stood at $53000.0, down from $57000.0 in the prior quarter.
- The five-year high for Operating Leases was $635000.0 in Q2 2021, with the low at $53000.0 in Q4 2025.
- Historically, Operating Leases has averaged $266000.0 across 5 years, with a median of $234000.0 in 2023.
- Annual changes were most pronounced in 2023 — Operating Leases sank 79.88% — and 2024, when it dropped 7.58%.
- Damora Therapeutics' Operating Leases stood at $448000.0 in 2021, then declined by 26.79% to $328000.0 in 2022, then slumped by 79.88% to $66000.0 in 2023, then dropped by 7.58% to $61000.0 in 2024, then retreated by 13.11% to $53000.0 in 2025.
- The last three Operating Leases figures came in at $53000.0 (Q4 2025), $57000.0 (Q3 2025), and $60000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 234,000.00 |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 440,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Mar 31, 2022 | 402,000.00 |
| Dec 31, 2021 | 448,000.00 |
| Sep 30, 2021 | 511,000.00 |
| Jun 30, 2021 | 635,000.00 |
| Mar 31, 2021 | 544,000.00 |
| Dec 31, 2020 | 541,000.00 |
| Sep 30, 2020 | 589,000.00 |
| Dec 31, 2019 | 211,000.00 |